These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30485879)

  • 1. Evaluation of Clinical Relevance of Drug-Drug Interaction Alerts Prior to Implementation.
    Meslin SMM; Zheng WY; Day RO; Tay EMY; Baysari MT
    Appl Clin Inform; 2018 Oct; 9(4):849-855. PubMed ID: 30485879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practitioners' views on computerized drug-drug interaction alerts in the VA system.
    Ko Y; Abarca J; Malone DC; Dare DC; Geraets D; Houranieh A; Jones WN; Nichol WP; Schepers GP; Wilhardt M
    J Am Med Inform Assoc; 2007; 14(1):56-64. PubMed ID: 17068346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug-drug interaction alerts.
    Baysari MT; Zheng WY; Li L; Westbrook J; Day RO; Hilmer S; Van Dort BA; Hargreaves A; Kennedy P; Monaghan C; Doherty P; Draheim M; Nair L; Samson R
    BMJ Open; 2019 Aug; 9(8):e026034. PubMed ID: 31427312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiering drug-drug interaction alerts by severity increases compliance rates.
    Paterno MD; Maviglia SM; Gorman PN; Seger DL; Yoshida E; Seger AC; Bates DW; Gandhi TK
    J Am Med Inform Assoc; 2009; 16(1):40-6. PubMed ID: 18952941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-drug interaction checking assisted by clinical decision support: a return on investment analysis.
    Helmons PJ; Suijkerbuijk BO; Nannan Panday PV; Kosterink JG
    J Am Med Inform Assoc; 2015 Jul; 22(4):764-72. PubMed ID: 25670751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall performance of a drug-drug interaction clinical decision support system: quantitative evaluation and end-user survey.
    Van De Sijpe G; Quintens C; Walgraeve K; Van Laer E; Penny J; De Vlieger G; Schrijvers R; De Munter P; Foulon V; Casteels M; Van der Linden L; Spriet I
    BMC Med Inform Decis Mak; 2022 Feb; 22(1):48. PubMed ID: 35193547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations to improve the usability of drug-drug interaction clinical decision support alerts.
    Payne TH; Hines LE; Chan RC; Hartman S; Kapusnik-Uner J; Russ AL; Chaffee BW; Hartman C; Tamis V; Galbreth B; Glassman PA; Phansalkar S; van der Sijs H; Gephart SM; Mann G; Strasberg HR; Grizzle AJ; Brown M; Kuperman GJ; Steiner C; Sullins A; Ryan H; Wittie MA; Malone DC
    J Am Med Inform Assoc; 2015 Nov; 22(6):1243-50. PubMed ID: 25829460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Patient-Specific Drug-Drug Interaction Alerting on the Frequency of Alerts: A Pilot Study.
    Horn J; Ueng S
    Ann Pharmacother; 2019 Nov; 53(11):1087-1092. PubMed ID: 31296026
    [No Abstract]   [Full Text] [Related]  

  • 9. A systematic review of the effectiveness of interruptive medication prescribing alerts in hospital CPOE systems to change prescriber behavior and improve patient safety.
    Page N; Baysari MT; Westbrook JI
    Int J Med Inform; 2017 Sep; 105():22-30. PubMed ID: 28750908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical evaluation of clinical decision support for the detection of drug-drug interactions.
    Smithburger PL; Buckley MS; Bejian S; Burenheide K; Kane-Gill SL
    Expert Opin Drug Saf; 2011 Nov; 10(6):871-82. PubMed ID: 21542665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Design for Drug-Drug Interaction Alerts Improves Prescribing Efficiency.
    Russ AL; Chen S; Melton BL; Johnson EG; Spina JR; Weiner M; Zillich AJ
    Jt Comm J Qual Patient Saf; 2015 Sep; 41(9):396-405. PubMed ID: 26289234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of drug-drug interaction alert rules in a pediatric hospital's electronic health record system using a visual analytics dashboard.
    Simpao AF; Ahumada LM; Desai BR; Bonafide CP; Gálvez JA; Rehman MA; Jawad AF; Palma KL; Shelov ED
    J Am Med Inform Assoc; 2015 Mar; 22(2):361-9. PubMed ID: 25318641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicians' responses to computerized drug-drug interaction alerts for outpatients.
    Yeh ML; Chang YJ; Wang PY; Li YC; Hsu CY
    Comput Methods Programs Biomed; 2013 Jul; 111(1):17-25. PubMed ID: 23608682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we heeding the warning signs? Examining providers' overrides of computerized drug-drug interaction alerts in primary care.
    Slight SP; Seger DL; Nanji KC; Cho I; Maniam N; Dykes PC; Bates DW
    PLoS One; 2013; 8(12):e85071. PubMed ID: 24386447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribers' reported acceptance and use of drug-drug interaction alerts: An Australian survey.
    Baysari MT; Dort BAV; Zheng WY; Li L; Hilmer S; Westbrook J; Day R
    Health Informatics J; 2022; 28(2):14604582221100678. PubMed ID: 35531625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing Drug-Drug Interaction Alerts Using a Multidimensional Approach.
    Daniels CC; Burlison JD; Baker DK; Robertson J; Sablauer A; Flynn PM; Campbell PK; Hoffman JM
    Pediatrics; 2019 Mar; 143(3):. PubMed ID: 30760508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic Health Record.
    Wright A; Aaron S; Seger DL; Samal L; Schiff GD; Bates DW
    J Gen Intern Med; 2018 Nov; 33(11):1868-1876. PubMed ID: 29766382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reasons provided by prescribers when overriding drug-drug interaction alerts.
    Grizzle AJ; Mahmood MH; Ko Y; Murphy JE; Armstrong EP; Skrepnek GH; Jones WN; Schepers GP; Nichol WP; Houranieh A; Dare DC; Hoey CT; Malone DC
    Am J Manag Care; 2007 Oct; 13(10):573-8. PubMed ID: 17927462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events targeted by drug-drug interaction alerts in hospitalized patients.
    Gatenby J; Blomqvist M; Burke R; Ritchie A; Gibson K; Patanwala AE
    Int J Med Inform; 2020 Nov; 143():104266. PubMed ID: 32961505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in high-priority drug-drug interaction alerts across institutions and electronic health records.
    McEvoy DS; Sittig DF; Hickman TT; Aaron S; Ai A; Amato M; Bauer DW; Fraser GM; Harper J; Kennemer A; Krall MA; Lehmann CU; Malhotra S; Murphy DR; O'Kelley B; Samal L; Schreiber R; Singh H; Thomas EJ; Vartian CV; Westmorland J; McCoy AB; Wright A
    J Am Med Inform Assoc; 2017 Mar; 24(2):331-338. PubMed ID: 27570216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.